| 1 |
35213993 | Association of P450 Oxidoreductase Gene Polymorphism with Tacrolimus Pharmacokinetics in Renal Transplant Recipients: A Systematic Review and Meta-Analysis. | 2022 Jan 22 |
7 |
| 2 |
35578867 | Impact of POR*28 Variant on Tacrolimus Pharmacokinetics in Kidney Transplant Patients with Different CYP3A5 Genotypes. | 2022 May 16 |
1 |
| 3 |
35629245 | Evaluation of Pharmacogenetics of Drug-Metabolizing Enzymes and Drug Efflux Transporter in Renal Transplants Receiving Immunosuppressants. | 2022 May 19 |
1 |
| 4 |
32225074 | Influence of POR*28 Polymorphisms on CYP3A5*3-Associated Variations in Tacrolimus Blood Levels at an Early Stage after Liver Transplantation. | 2020 Mar 26 |
4 |
| 5 |
32453653 | Effects of CYP3A5, ABCB1 and POR*28 polymorphisms on pharmacokinetics of tacrolimus in the early period after renal transplantation. | 2020 Dec |
3 |
| 6 |
30323313 | Impact of single nucleotide polymorphisms on P450 oxidoreductase and peroxisome proliferator-activated receptor alpha on tacrolimus pharmacokinetics in renal transplant recipients. | 2019 Feb |
1 |
| 7 |
31096684 | Impact of CYP3A5, POR, and CYP2C19 Polymorphisms on Trough Concentration to Dose Ratio of Tacrolimus in Allogeneic Hematopoietic Stem Cell Transplantation. | 2019 May 15 |
3 |
| 8 |
28094348 | Weight of ABCB1 and POR genes on oral tacrolimus exposure in CYP3A5 nonexpressor pediatric patients with stable kidney transplant. | 2018 Jan |
1 |
| 9 |
29629825 | CYP3A pharmacogenetic association with tacrolimus pharmacokinetics differs based on route of drug administration. | 2018 Apr |
1 |
| 10 |
29878980 | Impact of POR and CYP3A5 Polymorphisms on Trough Concentration to Dose Ratio of Tacrolimus in the Early Post-operative Period Following Kidney Transplantation. | 2018 Oct |
4 |
| 11 |
30040022 | Tacrolimus population pharmacokinetic models according to CYP3A5/CYP3A4/POR genotypes in Chinese Han renal transplant patients. | 2018 Aug 1 |
1 |
| 12 |
28229376 | The Pharmacogenetics of Tacrolimus in Corticosteroid-Sparse Pediatric and Adult Kidney Transplant Recipients. | 2017 Jun |
2 |
| 13 |
26829596 | A Lack of Significant Effect of POR*28 Allelic Variant on Tacrolimus Exposure in Kidney Transplant Recipients. | 2016 Apr |
1 |
| 14 |
27498776 | The POR rs1057868-rs2868177 GC-GT diplotype is associated with high tacrolimus concentrations in early post-renal transplant recipients. | 2016 Sep |
7 |
| 15 |
26067485 | Multigene predictors of tacrolimus exposure in kidney transplant recipients. | 2015 Jul |
3 |
| 16 |
26227094 | The genetic polymorphisms of POR*28 and CYP3A5*3 significantly influence the pharmacokinetics of tacrolimus in Chinese renal transplant recipients. | 2015 Sep |
7 |
| 17 |
24061445 | Impact of POR*28 on the pharmacokinetics of tacrolimus and cyclosporine A in renal transplant patients. | 2014 Feb |
2 |
| 18 |
24089076 | P450 oxidoreductase *28 (POR*28) and tacrolimus disposition in pediatric kidney transplant recipients--a pilot study. | 2014 Apr |
3 |
| 19 |
24249597 | The role of pharmacogenetics in the disposition of and response to tacrolimus in solid organ transplantation. | 2014 Feb |
1 |
| 20 |
24465960 | Impact of the CYP3A5, CYP3A4, COMT, IL-10 and POR genetic polymorphisms on tacrolimus metabolism in Chinese renal transplant recipients. | 2014 |
1 |
| 21 |
24658827 | The influence of CYP3A, PPARA, and POR genetic variants on the pharmacokinetics of tacrolimus and cyclosporine in renal transplant recipients. | 2014 Jun |
1 |
| 22 |
24739669 | CYP3A5*3 and POR*28 genetic variants influence the required dose of tacrolimus in heart transplant recipients. | 2014 Dec |
2 |
| 23 |
24921414 | Impact of PPARA and POR polymorphisms on tacrolimus pharmacokinetics and new-onset diabetes in kidney transplant recipients. | 2014 Aug |
2 |
| 24 |
25322286 | Combined effects of CYP3A5*1, POR*28, and CYP3A4*22 single nucleotide polymorphisms on early concentration-controlled tacrolimus exposure in de-novo renal recipients. | 2014 Dec |
3 |
| 25 |
23097010 | Effect of the P450 oxidoreductase 28 polymorphism on the pharmacokinetics of tacrolimus in Chinese healthy male volunteers. | 2013 Apr |
3 |
| 26 |
24113216 | Single-nucleotide polymorphisms in P450 oxidoreductase and peroxisome proliferator-activated receptor-α are associated with the development of new-onset diabetes after transplantation in kidney transplant recipients treated with tacrolimus. | 2013 Dec |
2 |
| 27 |
21770725 | The P450 oxidoreductase *28 SNP is associated with low initial tacrolimus exposure and increased dose requirements in CYP3A5-expressing renal recipients. | 2011 Sep |
3 |